← Back to headlines
Arcellx Sells $80 Million in Stock Following Steep Drop and Rival Drug Emergence
Arcellx has completed an $80 million stock sale, which comes after a significant drop in its stock price and the emergence of a rival drug in the market.
22 Feb, 18:56 — 22 Feb, 18:56
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Long-Term Investment Strategy: 3 Stocks to Buy and Hold Forever
1m ago
OSC Report Suggests Gamification Can Benefit Investing
1m ago
The Stock Market Sounds an Alarm as Investors Get a Warning From the Federal Reserve. History Says This Could Happen Next. - The Globe and Mail
1m ago
Wall Street Bets on 'HALO' Companies with AI Immunity
1m ago